You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 4, April 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Botulinum Toxin: Beyond Cosmesis

Arch Dermatol. 2000;136:539-541.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

BOTULINUM TOXIN A has virtually revolutionized the minimally invasive approach to cosmetic enhancement of the upper face. Nevertheless, the road to its present cosmetic and noncosmetic applications could certainly be considered a journey of serendipity. In 1895, Emile P. Van Ermengem first isolated the evil microbe Clostridium botulinum from food and the postmortem tissue of victims who had died in Ellezelles, Belgium, after consuming raw, salted pork. Additionally, he was aware that this disease process was caused by a toxin produced by this bacterium. Nevertheless, it was not until 1946 that the toxin produced by this organism was first isolated in crystalline form by Edward J. Schantz at Camp Detrick in Maryland.

One of the most pivotal individuals in the history of the medicinal use of botulinum toxin was Dr Alan Scott, whose search for a nonsurgical treatment for strabismus brought him into contact with Schantz and his purified toxin. . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Lower Relapse Rate of Botulinum Toxin A Therapy for Axillary Hyperhidrosis by Dose Increase
Theodor Karamfilov, Helga Konrad, Kerstin Karte, and Uwe Wollina
Arch Dermatol. 2000;136(4):487-490.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Botulinum A Exotoxin for Hyperfunctional Facial Lines: Where Not to Inject
Alam et al.
Arch Dermatol 2002;138:1180-1185.
FULL TEXT  

Caveat Emptor (Buyer Beware)
Carruthers
Arch Dermatol 2002;138:1243-1244.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.